BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26188936)

  • 21. Pituitary adenomas in childhood and adolescence.
    Kane LA; Leinung MC; Scheithauer BW; Bergstralh EJ; Laws ER; Groover RV; Kovacs K; Horvath E; Zimmerman D
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1135-40. PubMed ID: 7525627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
    Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
    Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
    Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
    Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.
    Mastronardi L; Guiducci A; Puzzilli F
    BMC Cancer; 2001; 1():12. PubMed ID: 11570981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
    Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
    Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
    Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
    Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of corticotropin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential.
    Xu B; Sano T; Yamada S; Li CC; Hirokawa M
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1220-5. PubMed ID: 10720066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody.
    Pizarro CB; Oliveira MC; Coutinho LB; Ferreira NP
    Braz J Med Biol Res; 2004 Feb; 37(2):235-43. PubMed ID: 14762579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
    Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Aggressive Behavior and Invasive Features of Pituitary Adenomas Using Radiological, Surgical, Clinical and Histopathological Markers.
    Kucuk A; Bayram F; Ozturk F; Tumturk A; Diri H; Oral S; Tucer B; Durak AC; Kurtsoy A
    Turk Neurosurg; 2016; 26(5):671-7. PubMed ID: 27438615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas.
    Gejman R; Swearingen B; Hedley-Whyte ET
    Hum Pathol; 2008 May; 39(5):758-66. PubMed ID: 18439942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas.
    Losa M; Barzaghi RL; Mortini P; Franzin A; Mangili F; Terreni MR; Giovanelli M
    Am J Pathol; 2000 Jan; 156(1):245-51. PubMed ID: 10623673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation parameters and apoptosis indices in pituitary macroadenomas.
    Ruggeri RM; Costa G; Simone A; Campennì A; Sindoni A; Ieni A; Cavallari V; Trimarchi F; Curtò L
    J Endocrinol Invest; 2012 May; 35(5):473-8. PubMed ID: 21897111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.
    Lu JQ; Adam B; Jack AS; Lam A; Broad RW; Chik CL
    Endocr Pathol; 2015 Sep; 26(3):263-72. PubMed ID: 26187094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.